Literature DB >> 12115170

CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosus.

Amrie C Grammer1, Peter E Lipsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12115170     DOI： 10.1002/art.10287

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  12 in total

Review 1.  B cells as therapeutic targets in SLE.

Authors:  Iñaki Sanz; F Eun-Hyung Lee
Journal:  Nat Rev Rheumatol       Date:  2010-06       Impact factor: 20.543

Review 2.  B-lymphocyte lineage cells and the respiratory system.

Authors:  Atsushi Kato; Kathryn E Hulse; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-04       Impact factor: 10.793

Review 3.  Human regulatory B cells in health and disease: therapeutic potential.

Authors:  Claudia Mauri; Madhvi Menon
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

4.  Ultraviolet-A (UVA-1) radiation suppresses immunoglobulin production of activated B lymphocytes in vitro.

Authors:  M C A Polderman; C van Kooten; N P M Smit; S W A Kamerling; S Pavel
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

5.  Analysis of RAG expression by peripheral blood CD5+ and CD5- B cells of patients with childhood systemic lupus erythematosus.

Authors:  H Morbach; S K Singh; C Faber; P E Lipsky; H J Girschick
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

6.  CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus.

Authors:  Roman Puliaev; Irina Puliaeva; Lisbeth A Welniak; Abigail E Ryan; Mark Haas; William J Murphy; Charles S Via
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

7.  Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation.

Authors:  Erica L Carpenter; Rosemarie Mick; Jens Rüter; Robert H Vonderheide
Journal:  J Transl Med       Date:  2009-11-11       Impact factor: 5.531

8.  Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.

Authors:  Amrie C Grammer; Rebecca Slota; Randy Fischer; Hanan Gur; Hermann Girschick; Cheryl Yarboro; Gabor G Illei; Peter E Lipsky
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

9.  Systemic lupus erythematosus and the type I interferon system.

Authors:  Lars Rönnblom; Gunnar V Alm
Journal:  Arthritis Res Ther       Date:  2003-01-20       Impact factor: 5.156

10.  Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response.

Authors:  Magda Nakou; Georgios Katsikas; Prodromos Sidiropoulos; George Bertsias; Eva Papadimitraki; Amalia Raptopoulou; Helen Koutala; Helen A Papadaki; Herakles Kritikos; Dimitrios T Boumpas
Journal:  Arthritis Res Ther       Date:  2009-08-28       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.